QuickView for phosphatidylinositol 3-kinase complex, class III, type I (biogroup)

1. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
2. The Immunological Genome Project - Immune cell lineage differentiation and maturation
3. Brain regions from patients with schizophrenia, depression or bipolar disorder
4. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
5. L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens

There were no matches for phosphatidylinositol 3-kinase complex, class III, type I

1. Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
2. Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
3. Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas…
4. A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma…